1 / 54

HOT STUFF

HOT STUFF. Ionizing Radiation in Medicine. Objectives. History of nuclear medicine Benefits of Nuclear Medicine Radiation Biology: interactions and effects Diagnostic and Therapeutic Applications Common Nuclear Medicine procedures. Overview. Over 20 million procedures annually in US

PamelaLan
Download Presentation

HOT STUFF

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. HOT STUFF Ionizing Radiation in Medicine

  2. Objectives • History of nuclear medicine • Benefits of Nuclear Medicine • Radiation Biology: interactions and effects • Diagnostic and Therapeutic Applications • Common Nuclear Medicine procedures

  3. Overview • Over 20 million procedures annually in US • Provides information unobtainable by other means • Useful for diagnosis and therapy • Sensitive, can detect many diseases at early stages • Less expensive than exploratory surgery • Based on ionizing radiation • Allows evaluation of physiologic function • Non-invasive, painless

  4. Historical Perspectives • 1896 X radiation discovered by Roentgen • 1896 Ionizing radiation discovered by Becquerel • 1900 Quantum Hypothesis - Planck • 1905 Special Theory of Relativity - Einstein • Continuing interest led to development of the field of Radiation Physics • Advances allowed for the creation of isotopes • varying physical characteristics • 1951 FDA approves I131 as radiopharmaceutical

  5. How it Works Physical and Biological Considerations

  6. Basic Concept • Radiation is used to image or treat disease • external or internal source • Radiopharmaceutical is selected • physical characteristics of radiation source • biological characteristics of target cells • Radiation dose is administered to patient • inhalation, ingestion, injection, or external beam • Imaging is possible due to radiation energy • Therapy is possible due to radiotoxicity

  7. Radiation Physical Characteristics • Nucleus • protons, neutrons • neutrons “stabilize” nucleus • Nuclear instability • increasing nuclear mass => decreasing nuclear stability • Decay to stable state through loss of mass • as energy (E=mc2) in the form of photons • as particles: alpha, beta, positron, neutron • Radiological half-life • time to decay to one-half original activity

  8. RadiationDecay Products • Alpha particle • high mass (2 neutron, 2 protons) • low velocity • Beta • low mass (electron) • intermediate energy • Gamma • very low mass (photon, wave-particle duality) • energetic • Neutron • wide range of energies • activation

  9. Biological EffectsTissue Interaction • Ionizing Radiation Toxicity • disrupts cellular DNA • creates free radicals (peroxides) • Linear Energy Transfer (LET) • Tissue radiosensitivity • relative biological effect • uptake and elimination

  10. ToxicityCellular Effects • Function of ionization density • DNA bonds • repair mechanism overwhelmed • increased mutations • loss of ability to replicate • Free radicals • destruction of cellular contents

  11. Biological InteractionsLinear Energy Transfer (LET) • Measure of ionization density • ionizations/unit volume • Energy (eV) deposited per micrometer of travel • Low LET: gamma, beta, x-radiation • High LET: alpha, neutron radiation

  12. Linear Energy Transfer FIGURE 4.3 Penetrating power of alpha and beta particles. SOURCE: Courtesy of Joseph Jurcic, Memorial Sloan-Kettering Cancer Center.

  13. Biological Interactions Relative Biological Effect • Relative Biological Effect • relative effectiveness of different emissions in producing a biological effect • Quality factor (Q) • tissue effects of different types of radiation • photon, beta = 1 • neutron = 10 • alpha = 20

  14. Biological Interactions Tissue Radiosensitivity • Metabolic Rate • correlates with nutrient uptake rate • Tissue-specific nutrients, configuration • Replication rate • correlates with nutrient uptake rate • Elimination rate • biological half-life

  15. Biological Interactions Uptake and elimination • Nutrient/substrate uptake • attach nucliide to ligand • preferential uptake by target cells • Glucose in brain • Elimination • biological half-life • matabolism • physical half-life

  16. RadiopharmacySelection of Agent: Considerations • High LET • high energy deposition in target cells • ionizations produced in target cells • Low LET • little energy absorbed per unit weight • few ionizations produced in tissue • Target cell specificity • uptake • Exposure to surrounding tissue • ALARA

  17. Commonly used Isotopes

  18. Applications in Medicine Diagnostics

  19. Diagnostic Modalities • Positron Emission Tomography (PET) • Single Photon Emission Computed Tomography (SPECT) • Radioimmunoassay (RIA) • Scintigraphy • Co-Registration • PET with MRI or CT

  20. Diagnostic Studies • Renal function • Coronary artery perfusion and cardiac function • Lung scans for respiratory and blood flow problems • Inflammation and infection • Ortho - fractures, infection, arthritis and tumors • Cancer detection and localization • lymph node evaluation, metastases • GI bleed • Thyroid function • Cerebral perfusion and abnormalities (seizures, memory loss, TBI)

  21. Diagnostic StudiesExposure Risk • Low energy gamma and positron radiations • Low exposure (dose) • comparable to diagnostic x-ray studies • natural background radiation • Low risk • dose received is not harmful to the patient

  22. Positron Emission Tomography • F18 FDG (fluorodeoxyglucose) typically used • weak positron emitter (low radiation dose) • Glucose analog • high uptake by brain, kidney, tumor, cardiac, and lung tissue • physiologic function • Excellent 3-D imaging • precise localization of tissue • monitoring therapeutic efficacy

  23. PET Brain

  24. Monitoring Therapy Esophageal tumor • PET more sensitive than CT for monitoring therapy • Expanding role for PET • Society of Nuclear Medicine, Wieder et.al. 2005

  25. Metastatic Breast Carcinoma • 27 year-old woman initially diagnosed with invasive ductal carcinoma by ultrasound guided biopsy. She underwent bilateral mastectomy, chemotherapy, and right-sided radiation

  26. Scintigraphy compared with PET • 27 year-old woman with history of breast cancer

  27. Case Study • 49 year old man presents for staging after grossly complete excision of a high grade fibrosarcoma from the right groin 1.5 weeks earlier • Uneventful surgery • Progressively increasing pain at the surgical site following removal of a drain 4 days earlier

  28. Post-surgical Abscess • 18F PET study

  29. PET Scan Availability • Increasing availabilty • over 1600 centers nationwide • http://petnetsolutions.com/zportal/portals/pat/find_a_pet_center/imagingcenter • Cost • $3 000 to $6 000 • 3 hours for study • Advantages • metabolic scanning • Provider information • http://www.petscaninfo.com/zportal/portals/phys

  30. SPECT • Less expensive than PET • $1000 v $3000 • Widely available • Commonly used for brain scans, perfusion studies • Sensitivity • cerebral ischemia 90% (v 20% CT) @ 8 hours • fracture 80% @ 24 hours, 95% @ 72 hours • seizure (ictal state) 81-93% • myocardial ischemia 90%

  31. Cerebral IschemiaSensitivity = 90% Clin Nucl Med. 2006 Jul;31(7):376-8

  32. SPECT MUGA Cardiac Function and EF • Tc99m labeled rbc’s • Left ventricular hypertrophy with global hypokinesis • 47 years old with history of CAD

  33. SPECT MUGA Cardiac Function and EF • Tc99m labeled rbc’s • Left ventricular hypertrophy with global hypokinesis • 47 years old with history of CAD

  34. T-cell lymphoma Emission from lateral thighs, right triceps, and inguinal lymph nodes

  35. Scintigraphy • Molecular imaging • indicator of metabolic activity • “hot spots” where uptake is high • Low radiation exposure • Short half-life, low energy gamma radiation • Extensive application in many specialties • Orthopedics, Cardiology, Endocrinology, etc

  36. Case Study X-ray of an 18-month-old boy unable to bear weight on his R leg s/p twisting injury x 2d

  37. Bone Scan at 7 days post-injury

  38. Case Study 18 yo. male with darkening urine, worsening muscle pain, and decreasing urine output over the past 3 days after one day of intense physical exercise

  39. Rhabdomyolisis • Elevated kidney uptake w/o bladder activity • Decreased activity in vastus medialis suggests necrosis

  40. PET/CT Co-registration • Provides anatomical and physiological information

  41. Applications in Medicine Therapeutics

  42. Therapeutic Modalities • Brachytherapy • Ablation • Targeted Alpha Therapy • Gamma knife • External Beam • Boron Neutron Capture Therapy

  43. Therapeutic ApplicationsExamples • Cancer Treatment • Tumor destruction • Palliation of pain • Marrow Transplants

  44. Brachytherapy • Radioactive “seeds” emplaced in surgically implanted tubes • Dose calculation by medical physicist • Tumour geometry determined through imaging modalities

  45. Prostate Cancer Treatment • Tube placement geometry allows creation of interlocking radiation field around target • Field maximizes dose to target while minimizing collateral damage

  46. Iodine Ablation • Ingestion of radioactive cocktail I131 • Dose delivered after surgical thyroidectomy • Patient becomes radioactive • Hospitalized until safe for general public

  47. Targeted Alpha Therapy • Carrier molecule “tagged” with alpha emitter • monoclonal antibodies • Delivery of alpha-emitting isotopes to target • High LET • capable of killing in a range of 1 to 3 cells • Leukemia cells and small solid tumors • Myeloid leukemias, prostate cancer, and lymphoma treatments are under study

  48. Monoclonal AntibodyRadioactive Source Chelated to Agent

  49. BNCT • Boron Neutron Capture Therapy • Boron delivered to target cells • Neutron irradiation => activiation of boron • 11Boron decay yields alpha particles • High LET of alpha deposits energy within 3 cell diameters • kills target while minimizing effect to surrounding tissue

  50. Gamma Knife • Precise location and tumor geometry essential • Cobalt-60 source • high level of penetrating gamma rays • Two hundred one beams focused on target • Delivery controlled by shield • Frame emplaced to hold shield • Procedure lasts about 4 hours

More Related